Evofem Biosciences, Inc. provided sales guidance for the third quarter of 2023. For the expects sales to be $5.0 million to $5.2 million for the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0136 USD | -14.47% | +13.33% | -78.75% |
1st Jan change | Capi. | |
---|---|---|
-78.75% | 830K | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023